相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial
Toby M. Maher et al.
LANCET RESPIRATORY MEDICINE (2020)
Pirfenidone: Molecular Mechanisms and Potential Clinical Applications in Lung Disease
Saleela M. Ruwanpura et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres
Iulia Popescu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Hypersensitivity Pneumonitis Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory
Margaret L. Salisbury et al.
CHEST (2019)
Involvement of the myeloid cell compartment in fibrogenesis and systemic sclerosis
Gabriela Kania et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Oliver Distler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Pulmonary Complications of Rheumatoid Arthritis
Hamish Farquhar et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
Anna-Maria Hoffmann-Vold et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
Lutz Wollin et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Alteration of human macrophage phenotypes by the anti-fibrotic drug nintedanib
Nessrine Bellamri et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
The Role of Telomerase and Telomeres in Interstitial Lung Diseases: From Molecules to Clinical Implications
Nissim Arish et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
Olivier Bonhomme et al.
RHEUMATOLOGY (2019)
Telomeropathy in Chronic Hypersensitivity Pneumonitis
Demosthenes Bouros et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases
Aryeh Fischer et al.
CLINICAL RHEUMATOLOGY (2019)
New trajectories in the treatment of interstitial lung disease: treat the disease or treat the underlying pattern?
Julie Morisset et al.
CURRENT OPINION IN PULMONARY MEDICINE (2019)
Targeting cardiac fibrosis with engineered T cells
Haig Aghajanian et al.
NATURE (2019)
Mechanisms of lung disease development in rheumatoid arthritis
Dan Wang et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
K. R. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease
Jie Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2019)
Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease
Ayodeji Adegunsoye et al.
CHEST (2019)
Telomere length and genetic variant associations with interstitial lung disease progression and survival
Chad A. Newton et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
Muriel Elhai et al.
ARTHRITIS & RHEUMATOLOGY (2019)
The Aging Lung and Idiopathic Pulmonary Fibrosis
Swati Gulati et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2019)
Endotype-phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease
Anna-Maria Hoffmann-Vold et al.
EBIOMEDICINE (2019)
Transcriptional regulatory model of fibrosis progression in the human lung
John E. McDonough et al.
JCI INSIGHT (2019)
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Vincent Cottin et al.
RESPIRATORY RESEARCH (2019)
Lung function preservation in a phase 3 trial of tocilizumab (TCZ) in systemic sclerosis (SSc)
Christopher P. Denton et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF)
Andreas Guenther et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
NOX4 modulates macrophage phenotype and mitochondrial biogenesis in asbestosis
Chao He et al.
JCI INSIGHT (2019)
Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases
Ayodeji Adegunsoye et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2019)
Triple Angiokinase Inhibitor Nintedanib Directly Inhibits Tumor Cell Growth and Induces Tumor Shrinkage via Blocking Oncogenic Receptor Tyrosine Kinases
Frank Hilberg et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
Short-term Automated Quantification of Radiologic Changes in the Characterization of Idiopathic Pulmonary Fibrosis Versus Nonspecific Interstitial Pneumonia and Prediction of Long-term Survival
Federica De Giacomi et al.
JOURNAL OF THORACIC IMAGING (2018)
Activated human T lymphocytes inhibit TGFβ-induced fibroblast to myofibroblast differentiation via prostaglandins D2 and E2
Shannon H. Lacy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
The controversial role of mast cells in fibrosis
Peter Bradding et al.
IMMUNOLOGICAL REVIEWS (2018)
Aged polymorphonuclear leukocytes cause fibrotic interstitial lung disease in the absence of regulation by B cells
Jung Hwan Kim et al.
NATURE IMMUNOLOGY (2018)
Clinical spectrum and prognostic factors of possible UIP pattern on high-resolution CT in patients who underwent surgical lung biopsy
Yasuhiro Kondoh et al.
PLOS ONE (2018)
Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype
Gali Epstein Shochet et al.
RESPIROLOGY (2018)
Therapeutic effects of telomerase in mice with pulmonary fibrosis induced by damage to the lungs and short telomeres
Juan Manuel Povedano et al.
ELIFE (2018)
The Lung in Rheumatoid Arthritis Focus on Interstitial Lung Disease
Paolo Spagnolo et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Short telomere syndromes cause a primary T cell immunodeficiency
Christa L. Wagner et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
P. -A. Juge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis
P. Heukels et al.
RESPIRATORY RESEARCH (2018)
Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation
Koichiro Kamio et al.
RESPIRATORY RESEARCH (2018)
The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Omkar Desai et al.
FRONTIERS IN MEDICINE (2018)
The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
Amy L. Olson et al.
EUROPEAN RESPIRATORY REVIEW (2018)
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases
Vincent Cottin et al.
EUROPEAN RESPIRATORY REVIEW (2018)
Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence
Luca Richeldi et al.
EUROPEAN RESPIRATORY REVIEW (2018)
Idiopathic pulmonary fibrosis: pathogenesis and management
Giacomo Sgalla et al.
RESPIRATORY RESEARCH (2018)
Tissue remodelling in pulmonary fibrosis
Lars Knudsen et al.
CELL AND TISSUE RESEARCH (2017)
Therapeutic management of patients with rheumatoid arthritis and associated interstitial lung disease: case report and literature review
Andrea Picchianti Diamanti et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2017)
Pneumocystosis revealing immunodeficiency secondary to TERC mutation
Raphael Borie et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis
Pierre-Antoine Juge et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
SIRT3 deficiency promotes lung fibrosis by augmenting alveolar epithelial cell mitochondrial DNA damage and apoptosis
Renea P. Jablonski et al.
FASEB JOURNAL (2017)
Idiopathic pulmonary fibrosis
Luca Richeldi et al.
LANCET (2017)
Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis
Zhenzhen Li et al.
NEPHROLOGY (2017)
Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis
Cheilonda Johnson et al.
RESPIRATORY MEDICINE (2017)
Progressive Decline of Lung Function in Rheumatoid Arthritis-Associated Interstitial Lung Disease
Jorge A. Zamora-Legoff et al.
ARTHRITIS & RHEUMATOLOGY (2017)
CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis Data From Two Independent Cohorts
Minghua Wu et al.
ARTHRITIS & RHEUMATOLOGY (2017)
The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study
Brett Ley et al.
LANCET RESPIRATORY MEDICINE (2017)
Klotho, an antiaging molecule, attenuates oxidant-induced alveolar epithelial cell mtDNA damage and apoptosis
Seok-Jo Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2017)
Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease
Joshua J. Solomon et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Immune Mechanisms in Pulmonary Fibrosis
Saeed Kolahian et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2016)
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Dinesh Khanna et al.
LANCET (2016)
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P. Tashkin et al.
LANCET RESPIRATORY MEDICINE (2016)
Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
Veronika K. Jaeger et al.
PLOS ONE (2016)
Pulmonary manifestations of Sjogren's syndrome
Thomas Flament et al.
EUROPEAN RESPIRATORY REVIEW (2016)
Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis
Ram P. Naikawadi et al.
JCI INSIGHT (2016)
Epigenetics in idiopathic pulmonary fibrosis
Argyrios Tzouvelekis et al.
BIOCHEMISTRY AND CELL BIOLOGY (2015)
Telomere Length in Interstitial Lung Diseases
Reinier Snetselaar et al.
CHEST (2015)
Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations
Qing-Qing Zhu et al.
MEDICINE (2015)
Telomere dysfunction causes alveolar stem cell failure
Jonathan K. Alder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Interstitial Lung Disease in Scleroderma
Sara R. Schoenfeld et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2015)
Mice with Pulmonary Fibrosis Driven by Telomere Dysfunction
Juan M. Povedano et al.
CELL REPORTS (2015)
Advances in the Evaluation and Management of Esophageal Disease of Systemic Sclerosis
Dustin A. Carlson et al.
CURRENT RHEUMATOLOGY REPORTS (2015)
Pleuroparenchymal fibroelastosis: a rare interstitial lung disease
John C. English et al.
RESPIROLOGY CASE REPORTS (2015)
Cellular interactions in the pathogenesis of interstitial lung diseases
Gianluca Bagnato et al.
EUROPEAN RESPIRATORY REVIEW (2015)
Neutrophil extracellular traps promote differentiation and function of fibroblasts
Akrivi Chrysanthopoulou et al.
JOURNAL OF PATHOLOGY (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
L. van Bon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants
Simon L. F. Walsh et al.
THORAX (2014)
Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study
Paolo Fraticelli et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Interstitial Lung Disease Associated With Systemic Sclerosis and Idiopathic Pulmonary Fibrosis How Similar and Distinct?
Erica L. Herzog et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Interstitial lung disease
Katerina M. Antoniou et al.
EUROPEAN RESPIRATORY REVIEW (2014)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Association Between the MUC5B Promoter Polymorphism and Survival in Patients With Idiopathic Pulmonary Fibrosis
Anna L. Peljto et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis
Angelo De Lauretis et al.
JOURNAL OF RHEUMATOLOGY (2013)
Detection of Alveolar Fibrocytes in Idiopathic Pulmonary Fibrosis and Systemic Sclerosis
Raphael Borie et al.
PLOS ONE (2013)
A Novel Telomerase Activator Suppresses Lung Damage in a Murine Model of Idiopathic Pulmonary Fibrosis
Claude Jourdan Le Saux et al.
PLOS ONE (2013)
The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population
Raphael Borie et al.
PLOS ONE (2013)
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis
Carmel J. Stock et al.
THORAX (2013)
Short-Term and Long-Term Outcomes of Interstitial Lung Disease in Polymyositis and Dermatomyositis A Series of 107 Patients
I. Marie et al.
ARTHRITIS AND RHEUMATISM (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis
Max A. Seibold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Antifibrotic activities of pirfenidone in animal models
C. J. Schaefer et al.
EUROPEAN RESPIRATORY REVIEW (2011)
Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease
E. J. Kim et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Global Impairment of CD4+CD25+FOXP3+ Regulatory T Cells in Idiopathic Pulmonary Fibrosis
Ioannis Kotsianidis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide
I. Sabnani et al.
RHEUMATOLOGY (2009)
BIBF 1120: Triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy
Frank Hilberg et al.
CANCER RESEARCH (2008)
Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis
Hisashi Oku et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Cellular and molecular mechanisms of fibrosis
T. A. Wynn
JOURNAL OF PATHOLOGY (2008)
Host-Environment Interactions in Exposure-Related Diffuse Lung Diseases
David M. Brass et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Effects of 1-year treatment with CycNophosphamilde on outcomes at 2 years in scleroderma lung disease
Donald P. Tashkin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis
Javier Rangel-Moreno et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Interstitial lung disease in primary Sjogren syndrome
Joseph G. Parambil et al.
CHEST (2006)
Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis
C Turesson et al.
ARTHRITIS AND RHEUMATISM (2005)
Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome
D Bouros et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
分享论文
